search
Back to results

Automatic Oxygen Control (SPOC) in Preterm Infants (optimalSPOC)

Primary Purpose

Infantile Respiratory Distress Syndrome, Ventilator Lung; Newborn

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
SPOCnew
8s SpO2 averaging
SPOCold
2s SpO2 averaging
Sponsored by
University Hospital Tuebingen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infantile Respiratory Distress Syndrome

Eligibility Criteria

undefined - 34 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • gestational age at birth <34+1/7weeks and
  • invasive mechanical ventilation OR noninvasive ventilation OR continous positive airway pressure support and
  • Fraction of inspired oxygen above 0.21 before inclusion and
  • more than 2 hypoxaemic events (arterial oxygen saturation below 80%) within 8 hours before inclusion and
  • parental written informed consent

Exclusion Criteria (any of the following):

  • congenital pulmonary anomalies
  • congenital heart defects influencing SpO2 (i.e. cyanotic heart defects)
  • right-to -left shunt through a PDA
  • Severe neonatal complications during study period (sepsis, necrotising enterocolitis)
  • diaphragmatic hernia or other diaphragmatic disorders

Sites / Locations

  • Department of Neonatology, University Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

No Intervention

Experimental

Experimental

Active Comparator

Active Comparator

Arm Label

RMC only

SPOCnew and 2s SpO2 averaging

SPOCnew and 8s SpO2 averaging

SPOCold and 2s SpO2 averaging

SPOCold and 8s SpO2 averaging

Arm Description

routine manual control (RMC) of the fraction of inspired oxygen (FIO2)

routine manual control (RMC) + automatic oxygen control (SPOC) with "new" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 2s.

routine manual control (RMC) + automatic oxygen control (SPOC) with "new" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 8s.

routine manual control (RMC) + automatic oxygen control (SPOC) with "old" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 2s.

routine manual control (RMC) + automatic oxygen control (SPOC) with "old" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 8s.

Outcomes

Primary Outcome Measures

Proportion of time with SpO2 within target range
Comparison of proportion of time with SpO2 within target range and time above target range if no supplemental oxygen was administered at that time and within the preceding 30sec between the five treatment modalities

Secondary Outcome Measures

Proportion of Time with SpO2 above target range
Comparison of proportion of time with SpO2 above target range if supplemental oxygen was administered at that time or within the preceding 30sec .
Proportion of Time with SpO2 below target range
Comparison of proportion of time with SpO2 below target range.
Proportion of Time with Hypoxia
Comparison of proportion of time with SpO2 below 80%.
Proportion of Time with Hyperoxia
Comparison of proportion of time with SpO2 above 97% if supplemental oxygen was administered at that time or at anytime during the previous 30 seconds.
Stability of cerebral oxygenation
"Area under the curve" of cerebral tissue saturation or fraction of tissue oxygen extraction outside of the infants Median +- 5% or outside of the "safe" interval of 55-80% rcStO2.
Severe hypoxemic episodes
Rate of episodes with SpO2 <80% for at least 60seconds

Full Information

First Posted
December 20, 2018
Last Updated
January 2, 2019
Sponsor
University Hospital Tuebingen
Collaborators
Fritz Stephan GmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT03785899
Brief Title
Automatic Oxygen Control (SPOC) in Preterm Infants
Acronym
optimalSPOC
Official Title
Automatic Oxygen Control (SPOC) in Preterm Infants - Evaluation of a Revised Algorithm and Effect of Averaging Time of Pulse Oximetry Signal
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
August 3, 2018 (Actual)
Primary Completion Date
August 1, 2019 (Anticipated)
Study Completion Date
August 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Tuebingen
Collaborators
Fritz Stephan GmbH

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Single-center, randomised controlled, cross-over clinical trial in preterm infants born at gestational age below 34+1/7 weeks receiving supplemental oxygen and respiratory support (continous positive airway pressure (CPAP) or non-invasive ventilation (NIV) or invasive ventilation (IV)). Routine manual control (RMC) of the fraction of inspired oxygen (FiO2) will be tested against RMC supported by automatic control (SPOC) with "old"-algorithm and RMC supported by CLAC with "new"-algorithm. The first primary hypothesis is, that the use of the "new" algorithm results in more time within arterial oxygen saturation (SpO2) target range compared to RMC only. The a-priori subordinate hypothesis is, that the new algorithm results in more time within SpO2 target range compared to SPOCold. The second primary hypothesis is, that the use of 2 seconds averaging time of the SpO2 Signal results in more time within arterial oxygen saturation (SpO2) target range compared to the use of 8 seconds averaging interval of the SpO2 signal.
Detailed Description
BACKGROUND AND OBJECTIVE In preterm infants receiving supplemental oxygen, routine manual control (RMC) of the fraction of inspired oxygen (FiO2) is often difficult and time consuming. The investigators developed a system for closed-loop automatic control (SPOC) of the FiO2. The objective of this study is to test a revised, "new" algorithm with 3 adaptions against the former "old" algorithm and against RMC. The 3 adaptions are: Faster re-adjustment to baseline-FiO2 (baseline FiO2: mean FiO2 during the previous 5min) Delayed reduction of FiO2 below baseline FiO2 Maximum FiO2 adjustable by user The first primary hypothesis is, that the application of SPOCnew in addition to RMC results in more time within arterial oxygen saturation (SpO2) target range compared to RMC only. The a-priori subordinate hypothesis is, that the revised algorithm is more effective as the old algorithm to maintain the SpO2 in the target range. The second primary hypothesis is, that the shortening of averaging time used for the SpO2 Signal from 8 seconds to 2 seconds results in more time within SpO2 target range for both, SPOCnew and SPOCold. Further hypotheses for exploratory testing are, that the SPOC new algorithm will achieve a lower proportion of time with SpO2 above and below the target range, hyper- and hypoxia and an improved stability of cerebral oxygenation (measured as rcStO2 and rcFtO2E determined by Near-infrared spectroscopy) compared with SPOCold and RMC. Reduction of staff workload (estimated by number of manual adjustments per hour) by SPOC. Validation of a clinical scoring tool to monitor severity of apnea of prematurity. STUDY DESIGN The Study is designed as a single-center, randomized controlled, cross-over clinical trial in preterm infants receiving mechanical ventilation or nasal continuous positive airway pressure or non-invasive ventilation and supplemental oxygen (FiO2 above 0.21). Within a 30-hour period the investigators will compare 6 hours of RMC with 12-hour periods of RMC supported by SPOCnew algorithm or SPOCold algorithm, respectively. During intervals with SPOC control the SpO2 Signal averaging time will be 2 second or 8seconds , respectively, for 6 hours each.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infantile Respiratory Distress Syndrome, Ventilator Lung; Newborn

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
24 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
RMC only
Arm Type
No Intervention
Arm Description
routine manual control (RMC) of the fraction of inspired oxygen (FIO2)
Arm Title
SPOCnew and 2s SpO2 averaging
Arm Type
Experimental
Arm Description
routine manual control (RMC) + automatic oxygen control (SPOC) with "new" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 2s.
Arm Title
SPOCnew and 8s SpO2 averaging
Arm Type
Experimental
Arm Description
routine manual control (RMC) + automatic oxygen control (SPOC) with "new" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 8s.
Arm Title
SPOCold and 2s SpO2 averaging
Arm Type
Active Comparator
Arm Description
routine manual control (RMC) + automatic oxygen control (SPOC) with "old" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 2s.
Arm Title
SPOCold and 8s SpO2 averaging
Arm Type
Active Comparator
Arm Description
routine manual control (RMC) + automatic oxygen control (SPOC) with "old" algorithm of the fraction of inspired oxygen (FIO2). The SpO2 signal averaging time is 8s.
Intervention Type
Device
Intervention Name(s)
SPOCnew
Intervention Description
SPOC is an automated, algorithm based adjustment of the fraction of inspired oxygen in relation to arterial saturation (SPO2). The revised "new" algorithm is turned on.
Intervention Type
Device
Intervention Name(s)
8s SpO2 averaging
Intervention Description
The arterial saturation (SPO2) will be averaged over 8s.
Intervention Type
Device
Intervention Name(s)
SPOCold
Intervention Description
SPOC is an automated, algorithm based adjustment of the fraction of inspired oxygen in relation to arterial saturation (SPO2). The former "old" algorithm is turned on.
Intervention Type
Device
Intervention Name(s)
2s SpO2 averaging
Intervention Description
The arterial saturation (SPO2) will be averaged over 2s.
Primary Outcome Measure Information:
Title
Proportion of time with SpO2 within target range
Description
Comparison of proportion of time with SpO2 within target range and time above target range if no supplemental oxygen was administered at that time and within the preceding 30sec between the five treatment modalities
Time Frame
30 hours
Secondary Outcome Measure Information:
Title
Proportion of Time with SpO2 above target range
Description
Comparison of proportion of time with SpO2 above target range if supplemental oxygen was administered at that time or within the preceding 30sec .
Time Frame
30 hours
Title
Proportion of Time with SpO2 below target range
Description
Comparison of proportion of time with SpO2 below target range.
Time Frame
30 hours
Title
Proportion of Time with Hypoxia
Description
Comparison of proportion of time with SpO2 below 80%.
Time Frame
30 hours
Title
Proportion of Time with Hyperoxia
Description
Comparison of proportion of time with SpO2 above 97% if supplemental oxygen was administered at that time or at anytime during the previous 30 seconds.
Time Frame
30 hours
Title
Stability of cerebral oxygenation
Description
"Area under the curve" of cerebral tissue saturation or fraction of tissue oxygen extraction outside of the infants Median +- 5% or outside of the "safe" interval of 55-80% rcStO2.
Time Frame
30 hours
Title
Severe hypoxemic episodes
Description
Rate of episodes with SpO2 <80% for at least 60seconds
Time Frame
30 hours
Other Pre-specified Outcome Measures:
Title
Staff workload
Description
number of manual adjustments of inspired oxygen per time
Time Frame
30 hours
Title
Validation of clinical Apnea Score
Description
Validation of a modified Apnea Score monitored by clinical staff by correlation between Score and other secondary outcomes. The modified Apnoea Score aims to quantify the burden from apnoea-bradycardia-syndrome by assigning 1-2-4 or 8 points according to event severity. Points are summed up during each treatment period in this study.
Time Frame
30 hours

10. Eligibility

Sex
All
Maximum Age & Unit of Time
34 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: gestational age at birth <34+1/7weeks and invasive mechanical ventilation OR noninvasive ventilation OR continous positive airway pressure support and Fraction of inspired oxygen above 0.21 before inclusion and more than 2 hypoxaemic events (arterial oxygen saturation below 80%) within 8 hours before inclusion and parental written informed consent Exclusion Criteria (any of the following): congenital pulmonary anomalies congenital heart defects influencing SpO2 (i.e. cyanotic heart defects) right-to -left shunt through a PDA Severe neonatal complications during study period (sepsis, necrotising enterocolitis) diaphragmatic hernia or other diaphragmatic disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christoph E Schwarz, MD
Phone
+49707129-0
Ext
84742
Email
c.schwarz@med.uni-tuebingen.de
First Name & Middle Initial & Last Name or Official Title & Degree
Axel R Franz, MD
Phone
+49707129-0
Ext
83791
Email
axel.franz@med.uni-tuebingen.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph E Schwarz, MD
Organizational Affiliation
University of Tubingen, University Hospital, Dept. Neonatology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Neonatology, University Children's Hospital
City
Tübingen
ZIP/Postal Code
72076
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christoph E Schwarz, MD
Phone
+49707129-0
Ext
80895
Email
c.schwarz@med.uni-tuebingen.de
First Name & Middle Initial & Last Name & Degree
Axel R Franz, MD
Phone
+49707129-0
Ext
83791
Email
axel.franz@med.uni-tuebingen.de

12. IPD Sharing Statement

Citations:
PubMed Identifier
34819347
Citation
Schwarz CE, Kreutzer KB, Langanky L, Wolf NS, Braun W, O'Sullivan MP, Poets CF, Franz AR. Randomised crossover trial comparing algorithms and averaging times for automatic oxygen control in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2022 Jul;107(4):425-430. doi: 10.1136/archdischild-2021-322096. Epub 2021 Nov 24.
Results Reference
derived

Learn more about this trial

Automatic Oxygen Control (SPOC) in Preterm Infants

We'll reach out to this number within 24 hrs